Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-15 Purchase | 2023-06-20 9:00 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 62,000 | $13.13 | $814,196 | 7,277,000 (Indirect) | View |
2023-06-05 Purchase | 2023-06-07 8:10 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 15,000 | $13.05 | $195,681 | 7,215,000 (Indirect) | View |
2023-05-25 Purchase | 2023-05-30 7:01 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 200,000 | $13.04 | $2,608,707 | 7,200,000 (Indirect) | View |
2023-05-17 Purchase(A) | 2023-05-19 9:12 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 96,000 | $13.22 | $1,269,375 | 7,000,000 (Indirect) | View |
2023-05-17 Purchase | 2023-05-19 8:00 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 60,000 | $13.07 | $784,228 | 6,964,000 (Indirect) | View |
2023-05-11 Purchase | 2023-05-15 9:09 pm | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 290,000 | $12.34 | $3,577,411 | 6,904,000 (Indirect) | View |
2023-03-10 Purchase | 2023-03-14 5:00 pm | Innoviva Inc. | INVA | Raifeld Pavel Chief Executive Officer | 3,000 | $10.87 | $32,603 | 9,799 (Direct) | View |
2022-07-08 Purchase | 2022-07-13 9:27 pm | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) | View |
2022-03-31 Purchase | 2022-04-01 4:52 pm | Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner | 5,385,208 | $5 | $26,926,040 | 44,441,416 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-31 Option Award | 2023-08-31 8:12 pm | 2024-11-20 2033-11-20 | Innoviva Inc. | INVA | Basso Stephen Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
2023-08-18 Tax Withholding | 2023-08-31 1:58 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 785 | $13.64 | 51,152 (Direct) | View |
2023-07-31 Option Award | 2023-08-02 9:32 pm | 2024-07-31 2033-07-31 | Innoviva Inc. | INVA | Koziel Margaret Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:57 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | Srivastava Sapna Director | 26,495 | $0 | 42,673 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:56 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | Birx Deborah Director | 26,495 | $0 | 78,984 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:54 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | Schlesinger Sarah J. Director | 26,495 | $0 | 124,706 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:53 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | Haimovitz Jules Director | 26,495 | $0 | 136,906 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:50 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | DiPaolo Mark Director | 26,495 | $0 | 124,706 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 5:47 pm | 2024-05-22 2033-05-21 | Innoviva Inc. | INVA | Odysseas Kostas D Director | 26,495 | $0 | 128,702 (Direct) | View |
2023-05-19 Tax Withholding | 2023-05-23 4:30 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 784 | $13.47 | 51,937 (Direct) | View |
2023-05-15 Option Award | 2023-05-23 4:30 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 1,576 | $0 | 51,937 (Direct) | View |
Ownership | 2023-05-15 9:05 pm | N/A N/A | Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 0 | $0 | 6,614,000 (Indirect) | View |
2023-04-13 Option Award | 2023-04-17 7:27 pm | 2024-02-20 2033-04-12 | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 34,344 | $0 | 91,145 (Direct) | View |
2023-02-17 Tax Withholding | 2023-02-22 4:31 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 1,852 | $12.42 | 36,801 (Direct) | View |
Ownership | 2023-01-06 5:05 pm | N/A N/A | Innoviva Inc. | INVA | Srivastava Sapna Director | 0 | $0 | 16,178 (Direct) | View |
2022-11-15 Option Award | 2022-11-22 4:30 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 433 | $0 | 38,653 (Direct) | View |
2022-11-18 Tax Withholding | 2022-11-22 4:30 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 828 | $13.55 | 38,653 (Direct) | View |
2022-08-19 Tax Withholding | 2022-08-22 6:16 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 830 | $14.12 | 39,048 (Direct) | View |
2022-05-20 Tax Withholding | 2022-05-23 4:31 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 828 | $16.29 | 39,878 (Direct) | View |
2022-05-13 Option Award | 2022-05-23 4:31 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 1,834 | $0 | 39,878 (Direct) | View |
2022-05-02 Option Award | 2022-05-04 3:43 pm | 2023-05-20 2032-05-01 | Innoviva Inc. | INVA | Raifeld Pavel Chief Executive Officer | 150,000 | $0 | 504,533 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:53 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | Birx Deborah Director | 22,647 | $0 | 52,489 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:52 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | Bickerstaff George Director | 22,647 | $0 | 147,207 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:51 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | Haimovitz Jules Director | 22,647 | $0 | 110,411 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:49 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | DiPaolo Mark Director | 22,647 | $0 | 98,211 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:48 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | Schlesinger Sarah J. Director | 22,647 | $0 | 98,211 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:47 pm | N/A N/A | Innoviva Inc. | INVA | Odysseas Kostas D Director | 12,647 | $0 | 92,207 (Direct) | View |
2022-04-25 Option Award | 2022-04-27 6:47 pm | 2023-04-25 2032-04-24 | Innoviva Inc. | INVA | Odysseas Kostas D Director | 10,000 | $10000 | 92,207 (Direct) | View |
2022-03-01 Option Award | 2022-03-02 8:40 pm | 2023-02-20 2032-02-28 | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 21,691 | $0 | 58,872 (Direct) | View |
2022-02-18 Other | 2022-02-23 1:05 pm | N/A 2022-08-18 | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 0 | $0 | 57,345,794 (Indirect) | View |
2022-02-18 Tax Withholding | 2022-02-22 5:06 pm | N/A N/A | Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer | 2,277 | $19.99 | 32,181 (Direct) | View |